Results 121 to 130 of about 28,484 (289)

The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies

open access: yesThe Prostate, EarlyView.
ABSTRACT Objective Prostate‐specific antigen (PSA)‐based screening has reduced prostate cancer (PCa) mortality but is associated with overdiagnosis/overtreatment. We developed and evaluated a blood‐based S2,3PSA% test to address the limitations of PSA‐based screening for PCa.
Hikari Miura   +17 more
wiley   +1 more source

Germline Testing for Prostate Cancer Patients: Evidence‐Based Evaluation of Genes Recommended by NCCN Guidelines

open access: yesThe Prostate, EarlyView.
ABSTRACT Background Approximately 50% of prostate cancer (PCa) patients meet the National Comprehensive Cancer Network (NCCN) guidelines for germline testing at diagnosis. However, the selection of genes for testing, their supporting evidence, and clinical interpretation remain poorly understood.
Jianfeng Xu   +19 more
wiley   +1 more source

Serial Ultrasonography Assessments of a Testicular Infarction Mimicking Testicular Tumor in a Behcet Disease Patient

open access: yesUrology Case Reports, 2014
Behcet disease (BD), a vasculitic disease, may present with a broad range of systemic manifestations. Urologic complications are rarely described in the literature, but when they occur, they present as epididymo-orchitis.
Zeid Al-Ani   +2 more
doaj  

Understanding urologic scientific publication patterns and general public interests on stone disease: lessons learned from big data platforms [PDF]

open access: bronze, 2020
Giovanni Scala Marchini   +9 more
openalex   +1 more source

Dual-Energy CT Applications in Urological Diseases [PDF]

open access: gold, 2023
Michaela Cellina   +9 more
openalex   +1 more source

Hyperuricemia and Urologic Disease

open access: yesUrogenital Tract Infection, 2017
In-Chang Cho, Seung Ki Min
openaire   +2 more sources

Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance

open access: yesThe Prostate, EarlyView.
ABSTRACT Background An accurate estimation of progression risk in patients with prostate cancer (PCa) amenable to active surveillance (AS) is still an unmet need. Among available biomarkers, we considered Prolaris cell‐cycle progression (CCP) test, “triple hit” phenotype (ERG overexpression, PTEN and prostein expression loss) and elevated expression ...
Marco Oderda   +14 more
wiley   +1 more source

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment [PDF]

open access: gold, 2018
Francesca Valentino   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy